Ennov is honored to announce that we are a Bronze sponsor of the 9th Annual European Drug Safety Pharma & Biotech Conference, a key event of the Pharmacovigilance World Tour. The conference will be held in Basel, Switzerland, on November 29-30, 2023.
This event unites the world’s leading minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology.
The key topics to be discussed include:
- Pharmacovigilance of advanced therapies
- Global strategies in PV reporting
- The impact of social media and mobile apps in pharmacovigilance
- Compliance with E2B(R3) implementation and insights from EudraVigilance and FDA case studies
- An interactive workshop on soft skills in the world of regulations
- The role of Natural Language Processing in PV reporting
- A vision for outsourcing and future trends in the pharma industry
- A focus on AI and automation in marketed pharmacovigilance, with a perspective on efficiency ROI
- Insightful sessions on drug safety in oncology, PV compliance enhancement, and much more
Join us to explore innovative approaches and solutions that can transform the future of pharmacovigilance. If you’re part of the pharmacovigilance community, you’ll have the chance to connect with the Ennov team to see how our unified platform serves the Life Sciences industry with Regulatory, Quality, Clinical, and PV solutions. Our team will be available to showcase Ennov’s unique capabilities, ensuring efficiency, risk reduction, and compliance across pharmacovigilance processes.
Don’t miss this opportunity to be at the forefront of the pharmacovigilance industry’s evolution and to network with experts and thought leaders. Engage with Ennov at the event and discover how our solutions can help you navigate the challenges and opportunities in drug safety and pharmacovigilance. Register now at the 9th Annual European Drug Safety Pharma & Biotech Conference website.
